On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual studio.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh